{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:19:10Z","timestamp":1760300350288},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Stroke-like episodes (SLEs) are typical cerebral manifestations of certain mitochondrial disorders (MIDs). They are characterised by a vasogenic edema in a non-vascular distribution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients concerns:<\/jats:title>\n            <jats:p>none<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>SLEs show up on cerebral MRI as stroke-like lesions (SLLs), characterised by vasogenic edema in a non-vascular distribution. SLLs expand in the acute stage and regress during the chronic stage. They show hyperperfusion in the acute stage and hypoperfusion in the chronic stage.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>SLLs respond favorably to antiseizure drugs, to No-precursors, steroids, the ketogenic diet, and antioxidants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcome:<\/jats:title>\n            <jats:p>SLLs end up as normal tissue, white matter lesion, grey matter lesion, cyst, laminar cortical necrosis, or the toenail sign.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>SLLs are a frequent manifestation of MIDs. They undergo dynamic changes in the acute and chronic stage. They need to be differentiated from ischemic stroke as they are differentially treated.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019141","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T04:53:44Z","timestamp":1582260824000},"page":"e19141","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic management of stroke-like episodes varies from that of encephalitis"],"prefix":"10.1097","volume":"99","author":[{"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,2]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"e15534","DOI":"10.1097\/MD.0000000000015534","article-title":"Mitochondrial A3243G mutation causes mitochondrial encephalomyopathy in a Chinese patient: case report","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40291-017-0279-7","article-title":"Genetic counselling for maternally inherited mitochondrial disorders","volume":"21","author":"Poulton","year":"2017","journal-title":"Mol Diagn Ther"},{"key":"R3-20230915","article-title":"MELAS. 2001 Feb 27 [updated 2018 Nov 29]","author":"El-Hattab","year":"2019","journal-title":"GeneReviews\u00ae [Internet]"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/jcp.2008.061267","article-title":"Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle from patients with mitochondrial DNA encoded tRNA gene defects","volume":"62","author":"De Paepe","year":"2009","journal-title":"J Clin Pathol"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/164_2016_2","article-title":"Toxicity of antiepileptic drugs to mitochondria","volume":"240","author":"Finsterer","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1097\/RLU.0b013e318286bd6f","article-title":"Multimodal imaging-monitored progression of stroke-like episodes in a case of MELAS syndrome","volume":"39","author":"Namer","year":"2014","journal-title":"Clin Nucl Med"},{"key":"R7-20230915","first-page":"5","article-title":"Arginine and citrulline for the treatment of MELAS syndrome","author":"El-Hattab","year":"2017","journal-title":"J Inborn Errors Metab Screen"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ajhg.2018.01.008","article-title":"NDUFB8 mutations cause mitochondrial complex I deficiency in individuals with leigh-like encephalomyopathy","volume":"102","author":"Piekutowska-Abramczuk","year":"2018","journal-title":"Am J Hum Genet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:26:59Z","timestamp":1694813219000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":8,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019141","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}